Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Lancet 394:131138 Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB et al (2018) Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Supplied as a lyophilized vial in 10 MG and 50 MG sizes, 10-vial kits
Wegovy is the version of semaglutide marketed to treat obesity by the longtime market leader in sales of GLP-1 diabetes and obesity treatments Novo Nordisk (NASDAQ Copenhagen: NOVO-B) , which also markets semaglutide to treat type 2 diabetes under the name Ozempic
Cellular Repair Power: The ability to repair DNA damage and inflammation caused by UV radiation
Other ingredients: Glycerin, Organic Cassava Syrup, Organic MCT Oil, Organic Orange Oil, Antioxidant Blend (Tocopherol Extract, Rosemary Extract), Organic Tangerine Oil, Organic Vanilla Extract
